Phototoxicity – from molecular descriptors to classification models

Abstract

Potential photoactivation of certain pharmaceuticals, cosmetic ingredients and natural products by sunlight (e.g., phenothiazines, arylsulfonamides, or coumarins) has to be considered early on in development in order to avoid serious adverse effects (for example phototoxic or photoallergic reactions). Current clinical trial registration guidelines (FDA May… (More)
DOI: 10.1186/1758-2946-3-S1-O10

Topics

  • Presentations referencing similar topics